20041003
 Technology & Health Brief -- Akzo Nobel NV: Remeron Antitrust Suit Settled In the U.S. for $59.8 Million   The Wall Street Journal,  Oct 4, 2004  Akzo Nobel NV said it reached a $59.8 million settlement over a U.S. antitrust litigation case on its Remeron antidepressant.   
